Our findings further assist in elucidating the role of POSTN in pancreatic cancer and POSTN may be a potential target to reprogram the immunosuppressive tumor microenvironment for pancreatic cancer immunotherapy. The gene discussed is POSTN; the disease is familial pancreatic carcinoma.